Virax Biolabs Group (NASDAQ: VRAX) surges on Monkey pox news

Shares of Virax Biolabs Group Ord Shs (NASDAQ: VRAX) are trading at more than 13$ a share up over $8 or a whooping 146% for the day. The stock currently has a 52 week high of $29. The stock is yet to find a true trading base as volatility has taken over.

So why is Virax Biolabs Group Ord Shs (NASDAQ: VRAX) surging ? 

Virax Biolabs Group Limited (Nasdaq: VRAX) has recently launched distribution of Monkeypox and Varicella-Zoster Viruses Real Time PCR Detection Kits in response to the world’s major Monkeypox outbreak. These specialized diagnostic kits are available now in Europe and can be found by contacting the company’s sales representatives.

VRAX claims itself to be an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral diseases, today. Other stocks on the move today include Aethlon Medical, Inc (NASDAQ:AEMD) up more than 44%, Ontrak Inc (NASDAQ:OTRK) up over 100%.

Please make sure to read and completely understand our disclaimer at While reading this article one must assume that we may be compensated for posting this content on our website.

Published by Benjamin Roussey

Benjamin Roussey is from Sacramento, California. He has two master’s degrees and served four years in the U.S. Navy. His bachelor’s degree is from CSUS (1999) where he was on a baseball pitching scholarship. His second master’s degree is an MBA in Global Management from the University of Phoenix (2006). He has worked for small businesses, public agencies, and large corporations. He has lived in Korea and Saudi Arabia where he was an ESL instructor. Benjamin spends his time in between Northern California and Cabo San Lucas, Mexico, committing himself to his craft of freelance and website writing.

Recent Stories

SignUp Now For Our Featured Newsletter